To embed, copy and paste the code into your website or blog:
The US regulators have been particularly focused on new players in the health tech space and the novel regulatory issues their products present within the existing legal framework. While the market is ripe with opportunity for innovative healthcare delivery models, tech companies should proceed with caution and ensure they understand the complex rigors and requirements of US healthcare regulations and enforcement regimes.
In this episode of our Connected With Latham podcast series, Washington D.C. See more +
The US regulators have been particularly focused on new players in the health tech space and the novel regulatory issues their products present within the existing legal framework. While the market is ripe with opportunity for innovative healthcare delivery models, tech companies should proceed with caution and ensure they understand the complex rigors and requirements of US healthcare regulations and enforcement
MediaMonks announces merger with Low Earth Orbit
January 27, 2021 10:40
S4 Capital’s MediaMonks has announced its fifth merger with the addition of Los Angeles based PR agency Low Earth Orbit.
The announcement:
S4 Capital and MediaMonks announced today its deepening expansion into the PR and communications space with the addition of Low Earth Orbit (L.E.O.). In joining, former Edelman executives Kevin King and Jess Clifton will be taking on senior leadership roles within MediaMonks. L.E.O was founded in 2019, following both Clifton and King’s departure from their leadership positions at Edelman, with the intention of building meaningful relationships between brands and consumers through innovative, creative experiences that impact culture and deliver measurable results. Since inception, the team has worked with client partners including Dole, Sierra Nevada, Facebook and LA28.
S4 Capital s MediaMonks announces 5th merger with addition of L E O adgully.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from adgully.com Daily Mail and Mail on Sunday newspapers.
Greenlight Biosciences Welcomes Thomas Crampton as Senior Vice President for Corporate Affairs
News provided by
Share this article
Share this article
BOSTON, Jan. 27, 2021 /PRNewswire/ GreenLight Biosciences, Inc., a biotechnology company focused on RNA research, design and manufacturing for human, animal and plant health, today announced the appointment of Thomas Crampton as the company s Senior Vice President for Corporate Affairs. Regulatory approvals last year moved RNA vaccines from the realm of scientific theory to medical reality and made them a core tool to combat the COVID-19 pandemic, said Charles Cooney, Chairman of GreenLight s board. Thomas brings the strategic experience, global outlook and leadership skills to scale GreenLight s ambition to match the transformative potential for RNA across life sciences, agriculture and beyond.
Our latest 60 second interview features Norton Rose Fulbright’s global and US chair and US Head of employment and labor Shauna Clark. Shauna talks to The Lawyer about the different ways in which the pandemic has impacted clients, about partnering with clients on diversity and inclusion initiatives, and her advice for junior lawyers at the start of their career.
Shauna Clark
What are some of the major trends expected to impact corporations in 2021?
As Norton Rose Fulbright’s US Head of Employment and Labor, I have found that the pandemic has impacted different clients in different ways, with some facing unforeseen challenges and others evaluating new opportunities. Many organizations have been forced to downsize and require legal guidance through this process. Others have required legal advice as they respond to the demands of working from home and implement new state and local regulations related to COVID-19. I expect this need will continue for the next several months.